New Biomarker miR-519a-3p Discovered for Asymptomatic Stages of Alzheimer’s Disease

Researchers have discovered a new biomarker, miR-519a-3p, that could be used for early diagnosis and treatment of Alzheimer’s disease in its asymptomatic stages. This microRNA is associated with the cellular prion protein and could enhance diagnostic accuracy in the early stages of the disease. Join our webinar to learn more about the role of organoids in advancing treatment for neurological disorders.